XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Collaborative Arrangements - AstraZeneca PLC (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cost of sales $ 3,419 $ 3,540  
Selling, general and administrative 2,552 2,483  
Research and development 3,621 3,992  
Other current assets 35,503   $ 38,782
Accrued and other current liabilities 12,772   15,694
AstraZeneca | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue from collaborative arrangement 356 330  
Cost of sales 83 82  
Selling, general and administrative 32 39  
Research and development 12 20  
Other current assets 358   424
Accrued and other current liabilities 15   $ 713
AstraZeneca | Alliance revenue - Lynparza | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue from collaborative arrangement 312 292  
AstraZeneca | Alliance revenue - Koselugo | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue from collaborative arrangement $ 44 $ 38